Search Results - "Van Bockstal, Mieke R."

Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast by Seijnhaeve, Elsa, Galant, Christine, Van Bockstal, Mieke R.

“…Insulinoma-associated protein-1 (INSM1), a transcription factor encoded by the insulinoma associated-1 gene, is a second-generation biomarker of neuroendocrine…”
Get full text

Comment on: “Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project” by Van Bockstal, Mieke R., Libbrecht, Louis, Galant, Christine

Get full text

Reply to Kawasaki et al Regarding “Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast” by Van Bockstal, Mieke R., Galant, Christine

Get full text

Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance by Van Bockstal, Mieke R, Wesseling, Jelle, Lips, Ester H, Smidt, Marjolein, Galant, Christine, van Deurzen, Carolien H M

“…In many countries, hormone receptor status assessment of ductal carcinoma in situ (DCIS) is routinely performed, as hormone receptor-positive DCIS patients are…”
Get full text

Breast-implant Related Silicone Lymphadenopathy: Asteroid Bodies do not Always Equal Sarcoidosis by Van Bockstal, Mieke R., Libbrecht, Louis, Dubail, Angélique, Berlière, Martine, Galant, Christine

“…Silicone breast implants are frequently used for breast augmentation for cosmetic purposes, as well as for breast reconstruction after prophylactic or…”
Get full text

Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER2-positive breast carcinoma by Van Bockstal, Mieke R, Dano, Hélène, Benhaddi, Naima, Dubois, Dominique, Vanderveken, Jonathan, Van Marcke, Cédric, Vandermeulen, Ad, Duhoux, Francois P, Vernaeve, Hilde, Berlière, Martine, Galant, Christine

“…Patients with HER2-positive invasive breast cancer that is node-positive and/or larger than 3 cm are generally treated with neoadjuvant chemotherapy (NAC). We…”
Get full text

Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers by Derouane, Françoise, Desgres, Manon, Moroni, Camilla, Ambroise, Jérôme, Berlière, Martine, Van Bockstal, Mieke R, Galant, Christine, van Marcke, Cédric, Vara-Messler, Marianela, Hutten, Stefan J, Jonkers, Jos, Mourao, Larissa, Scheele, Colinda L G J, Duhoux, Francois P, Corbet, Cyril

“…Neoadjuvant chemotherapy (NAC) is the standard of care for patients with early-stage triple negative breast cancers (TNBC). However, more than half of TNBC…”
Get full text

Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent by Agahozo, Marie Colombe, Westenend, Pieter J., van Bockstal, Mieke R., Hansum, Tim, Giang, Jenny, Matlung, Sanneke E., van Deurzen, Carolien H.M.

“…Ductal carcinoma in situ (DCIS) associated stromal changes and influx of immune cells might be mediators of progression to invasive breast cancer. We studied…”
Get full text

Ductal carcinoma in situ of the breast: immune cell composition according to subtype by Agahozo, Marie Colombe, van Bockstal, Mieke R., Groenendijk, Floris H., van den Bosch, Thierry P. P., Westenend, Pieter J., van Deurzen, Carolien H. M.

“…Ductal carcinoma in situ of the breast includes several subtypes with a divergent biological behavior. Data regarding the composition of ductal carcinoma in…”
Get full text

Histological interpretation of differentiated vulvar intraepithelial neoplasia (dVIN) remains challenging—observations from a bi-national ring-study by Dasgupta, Shatavisha, de Jonge, Elf, Van Bockstal, Mieke R., Wong-Alcala, Luthy S. M., Wilhelmus, Suzanne, Makkus, Lex A. C. F., Schelfout, Katrien, Van de Vijver, Koen K., Smits, Sander, Marbaix, Etienne, Koljenović, Senada, van Kemenade, Folkert J., Ewing-Graham, Patricia C.

“…Differentiated vulvar intraepithelial neoplasia (dVIN) is a premalignant lesion that is known to progress rapidly to invasive carcinoma. Accurate histological…”
Get full text

Periductal Stromal Tumors and Phyllodes Tumors Represent a Spectrum of Fibroepithelial Lesions: What Is in a Name? by Wabik, Amélie, Van Bockstal, Mieke R., Berlière, Martine, Galant, Christine

“…Periductal stromal tumors (PSTs) of the breast are considered as a rare subtype of phyllodes tumors. These rare fibroepithelial lesions display a biphasic…”
Get full text

Correction: Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent by Agahozo, Marie Colombe, Westenend, Pieter J., van Bockstal, Mieke R., Hansum, Tim, Giang, Jenny, Matlung, Sanneke E., van Deurzen, Carolien H.M.

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text

Artefactual Epithelial Displacement in a Papilloma with Extensive Usual Duct Hyperplasia Mimics a Solid Papillary Carcinoma with Invasive Growth by François, Aline, Galant, Christine, Berlière, Martine, Van Bockstal, Mieke R.

“…Mammary solid papillary carcinoma and usual duct hyperplasia (UDH) of the breast are morphological look-alikes, characterized by cellular streaming, solid…”
Get full text

Multinucleated Stromal Giant Cells in a Benign Fibroadenoma: Do Not Make a Mountain Out of a Molehill by Schoelinck, Jérémy, Galant, Christine, Berlière, Martine, Van Bockstal, Mieke R.

Get full text

Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast by Stanciu-Pop, Claudia, Nollevaux, Marie-Cécile, Berlière, Martine, Duhoux, Francois P., Fellah, Latifa, Galant, Christine, Van Bockstal, Mieke R.

“…Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease in terms of morphological characteristics, protein expression profiles, genetic…”
Get full text

Isolated CEP17 Copy Number Gain in Invasive Breast Cancer Results in a “Reverse” Amplification Status by Van Bockstal, Mieke R., Dubois, Dominique, Talpe, Stéphanie, Galant, Christine

Get full text

Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification by Van Bockstal, Mieke R., Agahozo, Marie Colombe, van Marion, Ronald, Atmodimedjo, Peggy N., Sleddens, Hein F. B. M., Dinjens, Winand N. M., Visser, Lindy L., Lips, Esther H., Wesseling, Jelle, van Deurzen, Carolien H. M.

“…Intratumour heterogeneity fuels carcinogenesis and allows circumventing specific targeted therapies. HER2 gene amplification is associated with poor outcome in…”
Get full text

Histiocytoid Ductal Carcinoma In Situ of the Breast: Not All Intraductal Foamy Cells Are Macrophages by Dano, Hélène, Galant, Christine, Coyette, Maude, Van Bockstal, Mieke R.

“…With the advent of screening mammography, the incidence of ductal carcinoma in situ (DCIS) has increased. DCIS accounts for around 20% of breast cancers…”
Get full text

Stemness in high-grade serous carcinoma of tubo-ovarian origin causes multiple immunohistochemical pitfalls: a case report by Van Bockstal, Mieke R, Augusto, David

Get more information

The 5-Year Paradigm in DCIS of the Breast: Unexpected Lessons From the NSABP B-43 Trial by Van Bockstal, Mieke R, Libbrecht, Louis, Galant, Christine

Get full text